Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma

Published:2020-05-31 Issue:6 Volume:38 Page:743-752
ISSN:0263-6484
Container-title:Cell Biochemistry and Function
language:en
Short-container-title:Cell Biochem Funct

Author:

Li Shuangling¹,Yang Hongli¹,Li Kun¹,Fan Guiling¹,Deng Li¹,Xu Changqing¹^ORCID

Affiliation:

1. Department of Gastroenterology, Shandong Provincial Qianfoshan HospitalThe First Hospital Affiliated with Shandong First Medical University Jinan People's Republic of China

Funder

Key Research and Development Project of Shandong Province

Medicine and Health Development Project of Shandong Province

Science and Technology Development Project of Shandong Province

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbf.3541

Reference46 articles.

1. Cholangiocarcinoma

2. Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows

3. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

4. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma

5. Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymidine phosphorylase facilitates retinoic acid inducible gene-I induced endothelial dysfunction;Cell Death & Disease;2023-04-26

2. A comprehensive pan-cancer analysis on the immunological role and prognostic value of TYMP in human cancers;Translational Cancer Research;2022-09

3. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen;Cancers;2022-05-23

4. Mechanisms of the antiangiogenic effects of aspirin in cancer;European Journal of Pharmacology;2021-05